Drug profile · INN
eltrombopag choline
ALVAIZ
eltrombopag choline (ALVAIZ) is a thrombopoietin receptor agonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — eltrombopag choline
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
eltrombopag choline (ALVAIZ) is a thrombopoietin receptor agonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Thrombopoietin receptor agonist
Primary target: Thrombopoietin receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is eltrombopag choline?
eltrombopag choline (ALVAIZ) is a thrombopoietin receptor agonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for eltrombopag choline?
ALVAIZ is a marketed brand name for eltrombopag choline. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of eltrombopag choline?
eltrombopag choline has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.